column
The new strategy in radionuclide therapy
ZHU Rui-sen
2005, 29(2): 49-49.
Abstract PDF
The study status of 131I-MIBG concomitant use with chemotherapy in the theray of neuroblastoma
ZHU Rui-sen
2005, 29(2): 50-52.
Abstract PDF
The clinical application of strontium-89 concomitant use with other modalities in the treatment of bone metastases
YUAN Zhi-bin
2005, 29(2): 53-56.
Abstract PDF
Treatment of non-uptaking 131I thyroid cancer
YU Yong-li
2005, 29(2): 57-63.
Abstract PDF
Potential therapeutic uses for rhTSH in thyroid diseases
LUO Quan-yong, ZHU Rui-sen
2005, 29(2): 63-66.
Abstract PDF
Current status of Bexxar for treatment of non-Hodgkin's lymphoma
CHEN Li-bo, ZHU Rui-sen
2005, 29(2): 67-70.
Abstract PDF
Progress of application study on sodium/iodide symporter as a radionuclide imaging and therapeutic gene
CHEN Li-bo, ZHU Rui-sen
2005, 29(2): 70-73.
Abstract PDF
Peptide receptor radionuclide therapy: current status and future directions
LUO Quan-yong
2005, 29(2): 74-78.
Abstract PDF
Advances in tumor treatment with labeled somatostatin analogues
MA Ji-xiao, YE Da-zhu
2005, 29(2): 79-84.
Abstract PDF
Investigation of quantitative measurement of brain metabolite concentration using 1H nuclear magnetic resonance spectroscopy
LIN Yan, RAO Hai-bing, WU Ren-hua
2005, 29(2): 85-88.
Abstract PDF
Progress in stereotactic radiotherapy for patients with brain metastases
ZHANG Zhong-min
2005, 29(2): 89-92.
Abstract PDF
Advances in imaging diagnosis of breast tumors
WANG Ling, ZHANG Chi-min
2005, 29(2): 93-96.
Abstract PDF